Cedar-Crosse Research Center — Chicago, Illinois

Cedar-Crosse Research Center is a clinical research site located in Chicago, Illinois, United States 60607.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Cedar-Crosse Research Center has participated in 42 clinical trials with 2 currently active.

Therapeutic areas: Type 2 Diabetes, Type 2 Diabetes Mellitus, Type 2 Diabetes (T2D).

Sponsors: Novo Nordisk A/S, Eli Lilly and Company, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cedar-Crosse Research Center?

Cedar-Crosse Research Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cedar-Crosse Research Center conducted?

Cedar-Crosse Research Center has 42 clinical trials on record, with 2 currently active. Their work covers Type 2 Diabetes, Type 2 Diabetes Mellitus, Type 2 Diabetes (T2D).

Is Cedar-Crosse Research Center accredited by Crixeo Health?

Cedar-Crosse Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cedar-Crosse Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.